GCG and Insulin resistance: Considering that hepatic insulin resistance is frequently seen even in the pre-diabetic state and is a major cause of the high level of gluconeogenesis, the glucose-lowering effect, which is independent of insulin secretion, might occur with liraglutide treatment by decreasing glucagon secretion and hepatic glucose production, suggesting that GLP-1 may not necessarily regulate insulin release46.